Cooley’s Anemia Foundation (CAF) is an American 501(c)(3) nonprofit organization that funds medical research and education to benefit individuals living with the genetic blood disorder thalassemia.
[3] All applications are examined and discussed by a Medical Review Committee, composed of individuals with expertise in various aspects of thalassemia research and treatment.
Published medical research funded in whole or in part by the Foundation includes: Since 1964,[6] the Foundation has partnered with the New York Academy of Sciences to present periodic symposia specifically focusing on the current status and future directions of clinical care and research in the area of thalassemia.
These Symposia bring together experts in thalassemia from around the world and offer an opportunity for clinicians, scientists, nurses and others involved in thalassemia care and research to share information and learn about up-to-date therapies and strategies that can have a current and future impact on patient care.
As a lifelong disorder, individuals born with thalassemia face a wide range of challenges from infancy onward.